SCL Science Past Earnings Performance

Past criteria checks 0/6

SCL Science's earnings have been declining at an average annual rate of -6%, while the Medical Equipment industry saw earnings growing at 18.7% annually. Revenues have been growing at an average rate of 37.5% per year.

Key information

-6.0%

Earnings growth rate

-1.0%

EPS growth rate

Medical Equipment Industry Growth22.7%
Revenue growth rate37.5%
Return on equity-18.6%
Net Margin-83.0%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Is SCL Science (KOSDAQ:246960) Using Too Much Debt?

May 21
Is SCL Science (KOSDAQ:246960) Using Too Much Debt?

Is InnoTherapy (KOSDAQ:246960) Using Debt In A Risky Way?

Apr 01
Is InnoTherapy (KOSDAQ:246960) Using Debt In A Risky Way?

InnoTherapy (KOSDAQ:246960) Has Debt But No Earnings; Should You Worry?

Dec 15
InnoTherapy (KOSDAQ:246960) Has Debt But No Earnings; Should You Worry?

Revenue & Expenses Breakdown

How SCL Science makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A246960 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 243,773-3,1302,7351,155
30 Jun 243,059-1,8302,7451,235
31 Mar 242,269-4,4312,5631,231
31 Dec 231,322-5,0262,6621,235
30 Sep 23809-5,4502,4051,259
30 Jun 23625-7,7202,7251,314
31 Mar 23483-5,5842,9351,253
31 Dec 22370-5,9723,0371,338
30 Sep 22349-7,0873,5631,358
30 Jun 22340-5,7523,4331,243
31 Mar 22425-5,4713,2461,500
31 Dec 21507-5,0293,0921,423
30 Sep 21539-3,0112,9461,447
30 Jun 21627-3,5492,7411,524
31 Mar 21612-3,2512,7121,246
31 Dec 20596-3,0472,6371,239
30 Sep 20657-3,7812,5991,178
30 Jun 20622-3,5292,4611,012
31 Mar 20668-3,5492,540979
31 Dec 19693-3,9893,169958
30 Sep 19711-3,6803,022964
30 Jun 19695-3,6033,065967
31 Mar 19578-3,3792,670973
31 Dec 18512-2,5741,908816
30 Sep 18382-2,9691,902675
30 Jun 18284-2,8381,844459
31 Mar 18257-2,8871,826498
31 Dec 17203-3,0121,724652
31 Dec 16101-7781,303334
31 Dec 1514-4,8231,012264
31 Dec 1442-79425111

Quality Earnings: A246960 is currently unprofitable.

Growing Profit Margin: A246960 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A246960 is unprofitable, and losses have increased over the past 5 years at a rate of 6% per year.

Accelerating Growth: Unable to compare A246960's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A246960 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-13.3%).


Return on Equity

High ROE: A246960 has a negative Return on Equity (-18.64%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 19:19
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

SCL Science Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Seung Doo NaSK Securities Co., Ltd.